Healthcare provider profile · identity verified

Satyajeet Roy, MD FACP

Internal Medicine · CHERRY HILL, NJ · NPI 1437116829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	592	200
Amlodipine Besylate	Amlodipine Besylate	577	183
Rosuvastatin Calcium	Rosuvastatin Calcium	443	147
Levothyroxine Sodium	Levothyroxine Sodium	438	126
Losartan Potassium	Losartan Potassium	315	106
Metoprolol Succinate	Metoprolol Succinate	263	79
Metformin Hcl	Metformin Hcl	262	87
Omeprazole	Omeprazole	239	78
Lisinopril	Lisinopril	232	83
Gabapentin	Gabapentin	213	79
Pantoprazole Sodium	Pantoprazole Sodium	208	66
Alprazolam	Alprazolam	203	43
Fluticasone Propionate	Fluticasone Propionate	198	89
Simvastatin	Simvastatin	195	57
Hydrochlorothiazide	Hydrochlorothiazide	194	65
Albuterol Sulfate Hfa	Albuterol Sulfate	166	47
Tamsulosin Hcl	Tamsulosin Hcl	166	55
Eliquis	Apixaban	165	43
Famotidine	Famotidine	145	48
Lorazepam	Lorazepam	141	31
Montelukast Sodium	Montelukast Sodium	139	43
Glipizide Er	Glipizide	131	42
Zolpidem Tartrate	Zolpidem Tartrate	124	23
Carvedilol	Carvedilol	116	46
Sertraline Hcl	Sertraline Hcl	111	34
Alendronate Sodium	Alendronate Sodium	89	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	24
Metoprolol Tartrate	Metoprolol Tartrate	87	31
Donepezil Hcl	Donepezil Hcl	77	23
Escitalopram Oxalate	Escitalopram Oxalate	77	25
Pravastatin Sodium	Pravastatin Sodium	77	30
Diazepam	Diazepam	75	15
Furosemide	Furosemide	75	31
Glimepiride	Glimepiride	75	17
Finasteride	Finasteride	74	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	74	56
Tramadol Hcl	Tramadol Hcl	72	19
Duloxetine Hcl	Duloxetine Hcl	71	22
Azithromycin	Azithromycin	70	61
Esomeprazole Magnesium	Esomeprazole Magnesium	66	18
Ezetimibe	Ezetimibe	66	24
Methylprednisolone	Methylprednisolone	65	47
Meloxicam	Meloxicam	64	17
Pregabalin	Pregabalin	62	15
Allopurinol	Allopurinol	59	17
Clopidogrel	Clopidogrel Bisulfate	59	20
Diclofenac Sodium	Diclofenac Sodium	59	23
Jardiance	Empagliflozin	58	15
Naproxen	Naproxen	54	19
Trazodone Hcl	Trazodone Hcl	53	18
Mounjaro	Tirzepatide	51	suppressed
Metformin Hcl Er	Metformin Hcl	49	18
Mirtazapine	Mirtazapine	48	20
Hydroxyzine Hcl	Hydroxyzine Hcl	47	18
Clonazepam	Clonazepam	46	13
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	16
Paroxetine Hcl	Paroxetine Hcl	42	14
Prednisone	Prednisone	42	14
Ramipril	Ramipril	41	13
Valacyclovir	Valacyclovir Hcl	41	15
Doxycycline Hyclate	Doxycycline Hyclate	40	32
Ondansetron Hcl	Ondansetron Hcl	39	12
Amoxicillin	Amoxicillin	38	35
Atenolol	Atenolol	38	11
Celecoxib	Celecoxib	38	13
Clobetasol Propionate	Clobetasol Propionate	38	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Potassium Chloride	Potassium Chloride	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Meclizine Hcl	Meclizine Hcl	37	21
Synthroid	Levothyroxine Sodium	37	11
Bupropion Xl	Bupropion Hcl	36	12
Hydralazine Hcl	Hydralazine Hcl	36	13
Warfarin Sodium	Warfarin Sodium	36	15
Xarelto	Rivaroxaban	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Ibandronate Sodium	Ibandronate Sodium	35	14
Ibuprofen	Ibuprofen	35	22
Telmisartan	Telmisartan	35	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	12
Ozempic	Semaglutide	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	16
Ventolin Hfa	Albuterol Sulfate	31	13
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	14
Ketoconazole	Ketoconazole	26	12
Temazepam	Temazepam	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Valsartan	Valsartan	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	11
Irbesartan	Irbesartan	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Lactulose	Lactulose	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	21	suppressed
Risperidone	Risperidone	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Risedronate Sodium	Risedronate Sodium	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Nystatin	Nystatin	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Torsemide	Torsemide	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Topiramate	Topiramate	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Probenecid	Probenecid	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error